We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Interest in MicroRNA Research Driving Growth in Related Market Tools

By LabMedica International staff writers
Posted on 01 Jun 2012
Print article
A new study shows that an increased number of pharmaceutical and biotech companies are becoming interested in microRNA (miRNA) research due to advancements in molecular diagnostics and therapeutics. As a result, a larger number of distribution companies are offering miRNA research tools and expanding the spectrum of their applications to cater to a wider range of life science areas.

In a recent study titled Analysis of MicroRNA Tools and Services Market in Europe, Frost & Sullivan (Palo Alto, CA, USA; www.frost.com), a global research and analysis company, examined various miRNA tools and services, including expression profiling and phenotypic screening, to determine that miRNA research is expanding across different fields.

The analysis found that miRNA research has become increasingly prominent in the cardiovascular, virology, endocrinology, plant science, and genetic disease fields. This has caused several other fields to develop an interest in auditing their gene expression analyses or epigenetic research by profiling miRNAs, explained Vinodh Jyotikumar, research consultant, Frost & Sullivan.

As new miRNAs and their functions are discovered, additional research fields may adopt an interest in the role of miRNAs in their disciplines, leading to the need for a wider variety of research tools.

A surge in miRNA research over the past four years has already led several life sciences vendors to offer miRNA research instruments. As competition intensifies, market participants will need to expand and differentiate their product options and capabilities to accommodate a broader range of interested fields.

"Service providers that do not offer in-house technologies must differentiate themselves by expanding tool options or adding capabilities," added Mr. Jyotikumar. "Companies may opt to provide multiple microarrays from various vendors, develop their own tools or offer specialized products, such as multiplex panels aimed at specific diseases."

Analysis of MicroRNA Tools and Services Market in Europe is part of the Frost & Sullivan Clinical Diagnostics Growth Partnership Services program.


Related Links:
Frost & Sullivan

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.